Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan-Mar;12(1):1-3.
doi: 10.4103/UA.UA_135_19. Epub 2020 Jan 13.

The role of robot-assisted radical prostatectomy in high-risk organ-confined prostate cancer

Mohamad Waseem Salkini  1
Affiliations
Review

The role of robot-assisted radical prostatectomy in high-risk organ-confined prostate cancer

Mohamad Waseem Salkini. Urol Ann. 2020 Jan-Mar.

Abstract

The traditional open retropubic radical prostatectomy has an established role in the treatment of prostate cancer. However, it is well known to be morbid procedure with high complication rate. This bad reputation prevented utilizing it on a large scale for high risk prostate cancer. Utilizing the da Vinci® to preform radical prostatectomy decreased the morbidity of the procedure. Since the introduction of robotic prostatectomy, there have been hot debates on its role in the treatment of high risk disease. In this article we reviewed the current evidence on utilizing the surgical system in treating high risk organ confined prostate cancer.

Keywords: Complication; dissection; high risk; lymph node; organ confined; prostate cancer; robotic.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010;28:1117–23. - PMC - PubMed
    1. Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007;177:2106–31. - PubMed
    1. Huang J, Vicini FA, Williams SG, Ye H, McGrath S, Ghilezan M, et al. Percentage of positive biopsy cores: A better risk stratification model for prostate cancer? Int J Radiat Oncol Biol Phys. 2012;83:1141–8. - PubMed
    1. Zwergel U, Suttmann H, Schroeder T, Siemer S, Wullich B, Kamradt J, et al. Outcome of prostate cancer patients with initial PSA> or=20 ng/ml undergoing radical prostatectomy. Eur Urol. 2007;52:1058–65. - PubMed
    1. Stephenson AJ, Kattan MW, Eastham JA, Bianco FJ, Jr, Yossepowitch O, Vickers AJ, et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol. 2009;27:4300–5. - PMC - PubMed